Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 15, Number 3—March 2009

Dispatch

Hepatitis E Virus Antibodies in Patients with Chronic Liver Disease

Muslim Atiq, Norah J. Shire, Anna Barrett, Susan D. Rouster, Kenneth E. Sherman, and Mohamed T. ShataComments to Author 
Author affiliations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA (M. Atiq); University of Cincinnati College of Medicine, Cincinnati, Ohio, USA (N.J. Shire, A. Barrett, S.D. Rouster, K.E. Sherman, M.T. Shata)

Main Article

Figure 1

Relationship between anti-hepatitis E virus (HEV) immunoglobulin (Ig) G and chronic liver disease. Scattered plot of the optical density (OD) of anti-HEV IgG for both liver disease patients and control groups is shown; each point represents a subject. Means (0.63 and 0.13 for patients with chronic liver disease and for control group, respectively) are plotted as horizontal lines.

Figure 1. Relationship between anti-hepatitis E virus (HEV) immunoglobulin (Ig) G and chronic liver disease. Scattered plot of the optical density (OD) of anti-HEV IgG for both liver disease patients and control groups is shown; each point represents a subject. Means (0.63 and 0.13 for patients with chronic liver disease and for control group, respectively) are plotted as horizontal lines.

Main Article

Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external